HC Wainwright Estimates Transcat's Q1 Earnings (NASDAQ:TRNS)

Transcat, Inc. (NASDAQ:TRNS - Free Report) - Analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Transcat in a note issued to investors on Wednesday, May 21st. HC Wainwright analyst S. Buck forecasts that the scientific and technical instruments company will post earnings of $0.41 per share for the quarter. HC Wainwright has a "Buy" rating and a $116.00 price target on the stock. The consensus estimate for Transcat's current full-year earnings is $2.30 per share. HC Wainwright also issued estimates for Transcat's Q2 2026 earnings at $0.26 EPS, Q3 2026 earnings at $0.10 EPS and FY2026 earnings at $1.48 EPS.

TRNS has been the topic of several other research reports. Oppenheimer lowered shares of Transcat from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 29th. Wall Street Zen raised shares of Transcat from a "sell" rating to a "hold" rating in a research note on Tuesday, May 20th. Finally, Northland Securities reiterated a "market perform" rating and set a $85.00 target price (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $114.00.

Transcat Trading Down 0.3%

TRNS stock traded down $0.31 during midday trading on Friday, reaching $91.32. The stock had a trading volume of 70,643 shares, compared to its average volume of 82,161. The firm has a market cap of $850.10 million, a price-to-earnings ratio of 49.36 and a beta of 0.69. Transcat has a twelve month low of $67.56 and a twelve month high of $147.12. The company has a quick ratio of 1.98, a current ratio of 2.42 and a debt-to-equity ratio of 0.14. The business has a fifty day simple moving average of $79.46 and a two-hundred day simple moving average of $89.50.

Transcat (NASDAQ:TRNS - Get Free Report) last released its earnings results on Monday, May 19th. The scientific and technical instruments company reported $0.64 earnings per share for the quarter, missing analysts' consensus estimates of $0.66 by ($0.02). The firm had revenue of $77.13 million for the quarter, compared to the consensus estimate of $76.40 million. Transcat had a return on equity of 7.23% and a net margin of 6.22%. The business's quarterly revenue was up 8.8% compared to the same quarter last year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Jane Street Group LLC bought a new stake in Transcat in the first quarter valued at approximately $1,674,000. Fred Alger Management LLC grew its holdings in shares of Transcat by 1.6% in the 1st quarter. Fred Alger Management LLC now owns 216,218 shares of the scientific and technical instruments company's stock valued at $16,097,000 after buying an additional 3,317 shares during the period. Needham Investment Management LLC increased its position in shares of Transcat by 28.2% in the 1st quarter. Needham Investment Management LLC now owns 65,000 shares of the scientific and technical instruments company's stock valued at $4,839,000 after buying an additional 14,300 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in Transcat by 6.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 5,462 shares of the scientific and technical instruments company's stock worth $407,000 after buying an additional 325 shares during the period. Finally, Granahan Investment Management LLC raised its stake in Transcat by 12.9% during the 1st quarter. Granahan Investment Management LLC now owns 213,167 shares of the scientific and technical instruments company's stock worth $15,870,000 after buying an additional 24,404 shares during the period. Institutional investors own 98.34% of the company's stock.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.